Henry

IN THE UNITED STATES DISTRICT COURT FOR THE NORTHERN DISTRICT OF CALIFORNIA 7 JEAN E. HENRY, Case No. 19-cv-02869-CRB

Plaintiff,

ORDER GRANTING MOTION TO

v. DISMISS

BRIAN J. TYLER, et al., Defendants.

Widespread anticompetitive conduct in the generic pharmaceuticals industry has led to a Department of Justice investigation, a complaint brought by forty-nine Attorneys General (the “AG complaint”), and a plethora of antitrust and Securities Act lawsuits against generic drug manufacturers. Although McKesson Corp. (“McKesson”) is, for the most part, a generic drug wholesaler, it has not been entirely spared. It is a defendant in multiple civil actions arising from the scandal, including a securities fraud action pending before this court. Jean Henry’s derivative shareholder complaint (“the FAC”) builds off the allegations of earlier actions to accuse former and current McKesson executives and directors (collectively, “Defendants”) of breaching their fiduciary duties. Defendants…